The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Peptide Reclassification 2026: What It Means for Providers FDA to Review 7 Peptides for Compounding List in July 2026: BPC 157, Semax, Epitalon, and More HealingMaps Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy Buy GLOW Blend 99%+ Purity USA Third Party Testing